IL291351B1 - Compounds containing carbazole derivatives for the treatment of solid tumors - Google Patents

Compounds containing carbazole derivatives for the treatment of solid tumors

Info

Publication number
IL291351B1
IL291351B1 IL291351A IL29135122A IL291351B1 IL 291351 B1 IL291351 B1 IL 291351B1 IL 291351 A IL291351 A IL 291351A IL 29135122 A IL29135122 A IL 29135122A IL 291351 B1 IL291351 B1 IL 291351B1
Authority
IL
Israel
Prior art keywords
compositions
treatment
solid tumors
carbazole derivatives
carbazole
Prior art date
Application number
IL291351A
Other languages
English (en)
Hebrew (he)
Other versions
IL291351A (en
Original Assignee
Raziel Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Raziel Therapeutics Ltd filed Critical Raziel Therapeutics Ltd
Publication of IL291351A publication Critical patent/IL291351A/en
Publication of IL291351B1 publication Critical patent/IL291351B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL291351A 2019-09-15 2020-09-15 Compounds containing carbazole derivatives for the treatment of solid tumors IL291351B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962900557P 2019-09-15 2019-09-15
PCT/IB2020/000745 WO2021048626A1 (en) 2019-09-15 2020-09-14 Compositions for the treatment of solid tumors

Publications (2)

Publication Number Publication Date
IL291351A IL291351A (en) 2022-05-01
IL291351B1 true IL291351B1 (en) 2026-07-01

Family

ID=74866186

Family Applications (1)

Application Number Title Priority Date Filing Date
IL291351A IL291351B1 (en) 2019-09-15 2020-09-15 Compounds containing carbazole derivatives for the treatment of solid tumors

Country Status (7)

Country Link
US (1) US20220323411A1 (cg-RX-API-DMAC10.html)
EP (1) EP4031130A4 (cg-RX-API-DMAC10.html)
JP (1) JP7822308B2 (cg-RX-API-DMAC10.html)
CN (1) CN115066241A (cg-RX-API-DMAC10.html)
AU (1) AU2020347539B2 (cg-RX-API-DMAC10.html)
IL (1) IL291351B1 (cg-RX-API-DMAC10.html)
WO (1) WO2021048626A1 (cg-RX-API-DMAC10.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016203468A1 (en) 2015-06-15 2016-12-22 Raziel Therapeutics Ltd. Carbazole derivatives for the treatment of fibrotic diseases and related symptoms, and conditions thereof
WO2022234337A2 (en) * 2021-05-06 2022-11-10 Raziel Therapeutics Ltd. Crystalline carbazole derivative
WO2024100533A1 (en) * 2022-11-07 2024-05-16 Raziel Therapeutics Ltd. Crystalline carbazole derivative and methods of making thereof

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010042445A1 (en) * 2008-10-06 2010-04-15 Cleveland Biolabs, Inc. Carbazole compounds and therapeutic uses of the compounds
WO2013072915A1 (en) * 2011-11-15 2013-05-23 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Tricyclic compounds, compositions comprising them and uses thereof
WO2016203468A1 (en) * 2015-06-15 2016-12-22 Raziel Therapeutics Ltd. Carbazole derivatives for the treatment of fibrotic diseases and related symptoms, and conditions thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0311406D0 (en) * 2003-05-17 2003-06-25 Queen Mary & Westfield College Substituted phosphonate fluorescent sensors,and use thereof
AU2021213469B2 (en) * 2020-01-28 2026-06-04 Raziel Therapeutics Ltd. Compositions for the treatment of angiolipoma

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010042445A1 (en) * 2008-10-06 2010-04-15 Cleveland Biolabs, Inc. Carbazole compounds and therapeutic uses of the compounds
WO2013072915A1 (en) * 2011-11-15 2013-05-23 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Tricyclic compounds, compositions comprising them and uses thereof
WO2016203468A1 (en) * 2015-06-15 2016-12-22 Raziel Therapeutics Ltd. Carbazole derivatives for the treatment of fibrotic diseases and related symptoms, and conditions thereof

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
AN, JIAN, ET AL., SIGNIFICANCE OF CANCER-ASSOCIATED FIBROBLASTS IN THE REGULATION OF GENE EXPRESSION IN THE LEADING CELLS OF INVASIVE LUNG CANCER., 30 October 2012 (2012-10-30) *
CARUSO, A. ET AL., CARBAZOLE DERIVATIVES: A PROMISING SCENARIO FOR BREAST CANCER TREATMENT, 7 March 2016 (2016-03-07) *
HU, L. ET AL., SYNTHESIS AND STRUCTURE-ACTIVITY RELATIONSHIPS OF CARBAZOLE SULFONAMIDES AS A NOVEL CLASS OF ANTIMITOTIC AGENTS AGAINST SOLID TUMORS, 14 September 2006 (2006-09-14) *
LIU, L. X. ET AL., SYNTHESIS AND ANTITUMOR ACTIVITY OF NOVEL N-SUBSTITUTED CARBAZOLE IMIDAZOLIUM SALT DERIVATIVES, 19 August 2015 (2015-08-19) *
LUO, MIN, ET AL., CANCER-ASSOCIATED FIBROBLASTS ACCELERATE MALIGNANT PROGRESSION OF NON-SMALL CELL LUNG CANCER VIA CONNEXIN 43-FORMED UNIDIRECTIONAL GAP JUNCTIONAL INTERCELLULAR COMMUNICATION., 19 November 2018 (2018-11-19) *
SATURNINO, CARMELA, ET AL., INHIBITION OF HUMAN TOPOISOMERASE II BY N, N, N?TRIMETHYLETHANAMMONIUM IODIDE ALKYLCARBAZOLE DERIVATIVES., 22 October 2018 (2018-10-22) *
TSUTSUMI, L. S. ET AL., CARBAZOLE SCAFFOLD IN MEDICINAL CHEMISTRY AND NATURAL PRODUCTS: A REVIEW FROM 2010-2015, 3 March 2016 (2016-03-03) *

Also Published As

Publication number Publication date
JP2023503769A (ja) 2023-02-01
CN115066241A (zh) 2022-09-16
AU2020347539A1 (en) 2022-03-31
US20220323411A1 (en) 2022-10-13
AU2020347539B2 (en) 2026-06-04
EP4031130A4 (en) 2023-10-11
JP7822308B2 (ja) 2026-03-02
EP4031130A1 (en) 2022-07-27
IL291351A (en) 2022-05-01
WO2021048626A1 (en) 2021-03-18